A case-based examination of oral lavender essential oil as a non-pharmaceutical intervention for generalized anxiety disorder ...
NEW YORK and LONDON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today ...
SAN DIEGO, Sept. 25, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor therapies, ...
Two new studies published in Anaesthesia analyzing pain and other factors connected with day surgery in the UK show that ...
"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...
-- 30.2-month median progression-free survival with a median follow-up of 38.1 months in the Phase 1 study of anito-cel; median overall survival not reached -- -- Preliminary results from 58 patients ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today shared another compelling patient case study in which ...
BREAST CANCER TREATMENT CAN BE GRUELING. AND IT CAN ALSO MAKE FOR VERY LONG DAYS. AND A NEW STUDY NOW SHOWING HIGHER DOSES OF RADIATION GIVEN OVER FEWER SESSIONS WAS AS EFFECTIVE AS BEING GIVEN LOWER ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback